drugset / Trial / NCT02721550

A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC

NCT02721550 ↗

Phase 4 Terminated 2 enrolled Shandong Cancer Hospital and Institute
NaSingle-groupOpen-labelTreatment

Summary

This is a perspective, multicenter,single arm, open label study to evaluate the efficacy and safety of treatment with CMNa combined with preoperatie concurrent chemoradiotherapy in patients with locally advanced squamous cell esophageal carcinoma . Analyses of primary objective (pathologic Complete Response) will be done as defined in the protocol.

Timeline

Start
2016-08-01
Primary completion
2018-06-30
Completion
2018-06-30

Outcome

Outcome not reported

Stopped (Enrollment): “The number of enrollment cases is too small.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Glycididazole Small molecule 800 mg/m2 Intravenous

Indications